| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.76B | +8.1% |
| Cost of Revenue | $758.5M | +9.6% |
| R&D Expense | $426.7M | +5.9% |
| SG&A Expense | $619.1M | +114.4% |
| Operating Income | -$5.1M | -101.3% |
| Interest Expense | $143.3M | -7.7% |
| Pre-tax Income | -$172.9M | -161.6% |
| Income Tax | $33.5M | -71.7% |
| Net Income | -$206.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $684.2M | +20.9% |
| Accounts Receivable | $161.8M | -13.8% |
| Current Assets | $1.06B | +21.9% |
| Total Assets | $3.72B | +2.2% |
| Current Liabilities | $967.9M | +73.2% |
| Long-term Debt | $2.39B | -0.5% |
| Total Liabilities | $4.13B | +9.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $567.7M | +15.8% |
| Capital Expenditures | $36.3M | -11.2% |
| Investing Cash Flow | -$221.7M | +71.7% |
| Financing Cash Flow | -$230.0M | -37.6% |
| Free Cash Flow | $531.4M | +18.3% |
| -227.3% |
| EPS (Basic) | -$0.55 | -225.0% |
| EPS (Diluted) | -$0.55 | -225.0% |
| Stockholders' Equity |
| -$411.4M |
| -213.8% |